POSSIBLE EPIGENETIC CHANGES THAT COULD DRIVE PLATINUM RESISTANCE IN HIGH GRADE SEROUS OVARIAN CARCINOMA: DATA FROM AN IN-VITRO TREATMENT MODEL

被引:0
|
作者
Ergasti, Raffaella [1 ,2 ]
Lim, Mi Qi [2 ]
Giannone, Gaia [2 ]
Ennis, Darren P. [2 ]
Dye, Isabel C. A. [2 ]
Mirza, Hasan B. [2 ]
Russo, Giorgia [1 ,2 ]
Fagotti, Anna [1 ,3 ]
Scambia, Giovanni [1 ,3 ]
Mcneish, Iain [2 ]
机构
[1] Fondazione Policlinico Univ Agostino Gemelli IRCC, Rome, Italy
[2] Imperial Coll London, London, England
[3] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
D O I
10.1136/ijgc-2023-ESGO.782
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
597
引用
收藏
页码:A369 / A370
页数:2
相关论文
共 40 条
  • [21] In vitro reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
    Nakamura, Kohei
    Nakayama, Kentaro
    Kiyono, Tohru
    Ishikawa, Noriyoshi
    Minamoto, Toshiko
    Ishibashi, Tomoka
    Sanuki, Kaori
    Yamashita, Hitomi
    Ono, Ruriko
    Iida, Kouji
    Sasamori, Hiroki
    Sultana, Razia
    Hossain, Mohammad Mahmud
    Ishikawa, Masako
    Kyo, Satoru
    CANCER RESEARCH, 2017, 77
  • [22] Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance
    Kido, Kansuke
    Nojima, Satoshi
    Motooka, Daisuke
    Nomura, Yusuke
    Kohara, Masaharu
    Sato, Kazuaki
    Ohshima, Kenji
    Tahara, Shinichiro
    Kurashige, Masako
    Umeda, Daisuke
    Takashima, Tsuyoshi
    Kiyokawa, Hiroki
    Ukon, Koto
    Matsui, Takahiro
    Okuzaki, Daisuke
    Morii, Eiichi
    JOURNAL OF PATHOLOGY, 2023, 260 (01): : 56 - 70
  • [23] BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report
    Buttitta, Fiamma
    Di Marino, Pietro
    Felicioni, Lara
    Primavera, Francesca Chiara
    Ferro, Benedetta
    Zampacorta, Claudia
    Pasciuto, Maria Paola
    Rossetti, Rebecca
    Tudini, Marianna
    Marchetti, Antonio
    D'Angelo, Emanuela
    PATHOLOGICA, 2023, 115 (02) : 107 - 110
  • [24] Establishment of in vitro carcinogenic model of high-grade serous ovarian carcinoma using immortalized fallopian tubal secretory epithelial cell
    Nakamura, Kohei
    Nakayama, Kentaro
    Kiyono, Tohru
    Ishikawa, Noriyoshi
    Ishikawa, Masako
    Katagiri, Hiroshi
    Minamoto, Toshiko
    Ishibashi, Tomoka
    Sato, Emi
    Sanuki, Kaori
    Yamashita, Hitomi
    Iida, Kouji
    Sultana, Razia
    Kyo, Satoru
    CANCER RESEARCH, 2016, 76
  • [25] Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI
    Na, Inye
    Noh, Joseph J.
    Kim, Chan Kyo
    Lee, Jeong-Won
    Park, Hyunjin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] A comprehensive analysis of the expression, epigenetic and genetic changes of HNF1B and ECI2 in 122 cases of high-grade serous ovarian carcinoma
    Nemejcova, Kristyna
    Bartu, Michaela
    Hojny, Jan
    Hajkova, Nikola
    Michalkova, Romana
    Krkavcova, Eva
    Struzinska, Ivana
    Bui, Hiep Quang
    Dundr, Pavel
    Cibula, David
    Jirsova, Katerina
    ONCOLOGY LETTERS, 2021, 21 (03)
  • [27] Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression
    Holy, Petr
    Hlavac, Viktor
    Seborova, Karolina
    Susova, Simona
    Tesarova, Tereza
    Rob, Lukas
    Hruda, Martin
    Bouda, Jiri
    Bartakova, Alena
    Mrhalova, Marcela
    Kopeckova, Katerina
    Allah, Mohammad Al Obeed
    Spacek, Jiri
    Sedlakova, Iva
    Soucek, Pavel
    Vaclavikova, Radka
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (01) : 104 - 116
  • [28] SINGLE-CELL MAP OF THE DYNAMIC CHANGES UNDERLYING PLATINUM-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN HIGH-GRADE SEROUS TUBO-OVARIAN CARCINOMA
    Olbrecht, S.
    Busschaert, P.
    Loverix, L.
    Vandestichele, A.
    Laga, T.
    Van Gorp, T.
    Van Nieuwenhuysen, E.
    Han, S.
    Baert, T.
    Van Rompuy, A. S.
    Lambrechts, D.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A235 - A236
  • [29] The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment
    Micek, Hannah M.
    Yang, Ning
    Dutta, Mayuri
    Rosenstock, Lauren
    Ma, Yicheng
    Hielsberg, Caitlin
    Mccord, Molly
    Notbohm, Jacob
    Mcgregor, Stephanie
    Kreeger, Pamela K.
    SCIENCE ADVANCES, 2024, 10 (17):
  • [30] Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment
    Sriramkumar, Shruthi
    Metcalfe, Tara X.
    Lai, Tim
    Zong, Xingyue
    Fang, Fang
    O'Hagan, Heather M.
    Nephew, Kenneth P.
    PLOS ONE, 2022, 17 (08):